Apellis Pharmaceuticals, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

461,186

Value ($000)

11,585

Weight

0.0%

2019 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	11,585	0.0%	461,186	12/31/2025
2025 Q3	11/14/2025	22,455	0.1%	992,269	9/30/2025
2025 Q2	8/14/2025	8,113	0.0%	468,710	6/30/2025
2025 Q1	5/15/2025	5,550	0.0%	253,790	3/31/2025
2024 Q4	2/14/2025	11,037	0.0%	345,885	12/31/2024
2024 Q3	11/14/2024	23,492	0.1%	814,564	9/30/2024
2024 Q2	8/14/2024	26,434	0.1%	689,108	6/30/2024
2023 Q3	11/14/2023	2,064	0.0%	54,263	9/30/2023
2023 Q2	8/14/2023	13,064	0.1%	143,402	6/30/2023
2023 Q1	5/15/2023	4,369	0.0%	66,235	3/31/2023
2022 Q3	11/14/2022	7,339	0.0%	107,452	9/30/2022
2022 Q1	5/16/2022	3,731	0.0%	73,426	3/31/2022
2021 Q4	2/14/2022	3,601	0.0%	76,162	12/31/2021
2021 Q3	11/15/2021	11,493	0.1%	348,708	9/30/2021
2021 Q2	8/16/2021	9,783	0.1%	154,799	6/30/2021
2020 Q4	2/16/2021	452	0.0%	7,901	12/31/2020
2019 Q4	2/14/2020	513	0.0%	16,762	12/31/2019